http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101464004-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
filingDate | 2006-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101464004-B1 |
titleOfInvention | Benzamide compounds useful as histone deacetylase inhibitors |
abstract | The present invention relates to a benzamide compound of the formula (I) or a pharmaceutically acceptable salt or prodrug form thereof. The present invention also relates to a process for the preparation of the compounds, pharmaceutical compositions containing them, and other proliferative conditions sensitive to the inhibition of histone deacetylase (HDAC) ≪ RTI ID = 0.0 > and / or < / RTI >n n n n n n n n In the formula, R 1 is C 1 - 4 alkyl, C 3 - 4 cycloalkyl, C 1 - 4 alkoxy and C 3 - 4 is a carbon bonded pyrazole ring is optionally substituted with one or more groups selected from the cycloalkoxy. |
priorityDate | 2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 644.